Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	16.6	26.25	26.28	43.09	32.71	62.13
Cash & Short-Term Investments	16.6	26.25	26.28	43.09	32.71	62.13
Cash Growth	-47.13%	-0.15%	-39.00%	31.72%	-47.35%	1075.29%
Receivables	12.67	8.6	7.68	5.07	3.66	15.3
Inventory	1.4	1	1.4	1.4	2.9	3.2
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.2
Other Current Assets	2.62	3.54	4.22	3.68	4.25	5.31
Total Current Assets	33.4	39.48	39.68	53.33	43.61	86.14
Property, Plant & Equipment	30.7	29.6	29.61	8.82	4.18	3.18
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03
Other Intangible Assets	4.38	5.87	7.91	9.8	11.62	13.26
Long-Term Deferred Charges	-	0.7	-	-	-	-
Other Long-Term Assets	5.21	6.56	6.86	5.92	1.66	3.46
Total Assets	88.72	97.24	99.1	92.91	76.1	121.07
Accounts Payable	3.62	2.19	2.93	1.69	1.66	8.96
Accrued Expenses	9.57	9.91	7.71	8.22	7.67	7.79
Current Portion of Long-Term Debt	0.01	0.02	0.05	0.05	0.02	11.84
Current Portion of Leases	2.18	1.51	0.25	1.54	-	-
Current Unearned Revenue	2.77	0.68	0.32	0.96	1.85	3.53
Other Current Liabilities	-	-	22.15	10.38	17.76	-
Total Current Liabilities	18.15	14.32	33.42	22.84	28.96	32.13
Long-Term Debt	47.11	36.41	35.23	25	9.99	15.93
Long-Term Leases	25.08	25.44	25.16	5.25	-	-
Long-Term Unearned Revenue	0.1	0.2	0.3	0.4	0.8	1.4
Other Long-Term Liabilities	-	-	0.41	18.8	16.62	30.45
Total Liabilities	90.44	76.37	94.52	72.3	56.37	79.9
Common Stock	0.01	0.15	0.1	0.08	0.03	0.03
Additional Paid-In Capital	492.05	483.23	424.05	387.95	321.67	299.95
Retained Earnings	-493.78	-462.5	-419.57	-367.42	-301.97	-258.81
Total Common Equity	-1.72	20.88	4.58	20.61	19.73	41.17
Shareholders' Equity	-1.72	20.88	4.58	20.61	19.73	41.17
Total Liabilities & Equity	88.72	97.24	99.1	92.91	76.1	121.07
Total Debt	74.39	63.38	60.69	31.85	10.01	27.77
Net Cash (Debt)	-57.78	-37.14	-34.41	11.24	22.7	34.36
Net Cash Growth	-	-	-	-50.49%	-33.93%	-
Net Cash Per Share	-7.83	-5.73	-8.38	5.34	16.59	142.04
Filing Date Shares Outstanding	7.96	7.3	4.85	3.9	1.57	1.33
Total Common Shares Outstanding	7.95	7.27	4.81	3.88	1.54	1.33
Working Capital	15.25	25.17	6.27	30.5	14.65	54.02
Book Value Per Share	-0.22	2.87	0.95	5.31	12.81	31.00
Tangible Book Value	-21.13	-0.03	-18.36	-4.22	-6.92	12.88
Tangible Book Value Per Share	-2.66	-0.00	-3.82	-1.09	-4.50	9.69
Machinery	8.61	8.36	8.44	7.23	7.97	7.03
Construction In Progress	0.01	0.09	-	2.95	0.02	0.38
Leasehold Improvements	28.24	28.19	24.71	2.37	2.34	1.85

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q